Research Solutions, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSSS research report →
Range $3.5 – $4
Price Chart
About the company
Research Solutions, Inc. , through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.
- CEO
- Roy W. Olivier
- IPO
- 2010
- Employees
- 141
- HQ
- Henderson, NV, US
Get TickerSpark's AI analysis on RSSS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $73.41M
- P/E
- 24.12
- Fwd P/E
- 18.43
- PEG
- 0.20
- P/S
- 1.46
- P/B
- 3.04
- EV/EBITDA
- 11.68
- Div Yield
- 0.00%
- Gross Margin
- 52.01%
- Op Margin
- 7.43%
- Net Margin
- 5.92%
- ROE
- 14.37%
- ROIC
- 15.06%
Latest fiscal year · YoY change
- Revenue
- $48.31M-1.5%
- Gross Profit
- $25.07M+3.6%
- Op Income
- $3.59M
- Net Income
- $2.82M+123.0%
- EPS
- $0.09+118.4%
- OCF Growth
- -24.9%
- FCF Growth
- -25.3%
- 52W High
- $3.38
- 52W Low
- $1.77
- 50D MA
- $2.00
- 200D MA
- $2.25
- Beta
- 0.83
- RSI (14)
- 63
- Avg Volume
- 43.09K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Research Solutions posted modest revenue declines but improved gross margin and cash generation, while AI-related ARR and large enterprise deals continued to build momentum.· November 17, 2026
- Total revenue fell to $11.9 million from $12.3 million a year ago as transaction revenue softened, but platform subscription revenue rose 3.7% to $5.3 million.
- Gross margin improved to 53.6%, up 300 basis points year over year, helped by the mix shift toward higher-margin platform revenue and better transaction margins.
- Total ARR reached $22.5 million, up 5.7% year over year, with B2B ARR up 11.5% to $16.5 million and AI-related ARR at about $1.1 million, up 38% from fiscal 2026.
- Management said AI usage doubled to more than 33 million paper reads since the last call, and 49 business customers now have AI access in their contracts.
- The company closed a $1 million ARR deal and said the pipeline is above $5 million in ARR, while churn improved about 30% from a year ago but remains a concern.
First-quarter fiscal 2027 revenue was $11.9 million versus $12.3 million in the prior-year quarter. Platform subscription revenue increased 3.7% to $5.3 million, transaction revenue declined about 8% to approximately $6.6 million, and consolidated gross margin was 53.6%, up 300 basis points year over year. Gross profit rose 2.5% to $6.4 million, net income was $765,000 or $0.02 per diluted share versus $749,000 or $0.02 a year ago, and adjusted EBITDA was $1 million or an 8.6% margin. Operating cash flow was approximately $1.2 million, and the company ended with $12.6 million in cash and no long-term debt. For forward commentary, management said the large deal announced last week will flow into the coming quarter, B2C looks roughly in line with expectations but could have some upside, and full-year EBITDA is likely to be a bit lower than previously discussed because of the timing of the new booking and some nonrecurring spend, though the run rate should continue to improve.
Roy Olivier framed the quarter as evidence that the company’s AI strategy is taking hold, saying AI is coming through the company rather than around it. He highlighted stronger publisher participation, growing customer adoption, a pipeline above $5 million in ARR, and a stronger balance sheet that gives the company room to invest where it sees the biggest shareholder returns. His tone was constructive but measured: he repeatedly noted churn is still not where they want it to be, even as it has improved.
Dave Kutil focused on the mix shift and the financial flow-through from that shift. He detailed revenue of $11.9 million, gross margin of 53.6%, gross profit of $6.4 million, adjusted EBITDA of $1 million, and cash flow from operations of $1.2 million; he also noted cash of $12.6 million, no debt, and no borrowings on the $500,000 revolver. He said the company paid $1.2 million of Scite earn-out payments during the quarter and has completed 6 of the 8 quarterly payments as of November 2, while still maintaining flexibility to finish the remaining obligations and invest in the business.
Analysts pressed on B2B bookings versus churn, the impact of the large $1 million deal, weaker transaction revenue, and whether AI agents were substituting for document delivery. Management said quarterly B2B bookings were about $500,000, churn has improved roughly 30% from a year ago but has averaged about $300,000 over the last three quarters, and the large deal is a 1-year contract with upside in years 2 and 3. On transaction softness, management said most of the decline is still driven by customer churn and some unexplained weakness, with agentic AI a possible but early-day factor. They also said larger deals take longer because of approvals and AI/IT reviews, but smaller deals remain quick at roughly 2 to 3 months.
The bull case is that AI-driven usage and enterprise adoption are scaling quickly: paper reads doubled to more than 33 million, 49 business customers now have AI in their contracts, and the company is already seeing hundreds of article and rights orders through AI assistants. Gross margin improved sharply, cash generation remains positive, and management believes the large enterprise deal is replicable rather than a one-off. With a pipeline above $5 million in ARR and several large opportunities in process, management sounded confident that the current trends can continue.
The main risks are that transaction revenue is still declining, churn remains elevated despite improvement, and management admitted it does not fully understand all the reasons for weakness in document delivery. Full-year EBITDA was guided lower than previously discussed because of delayed bookings and nonrecurring spend, and some of the AI and enterprise upside depends on long sales cycles and multi-stakeholder approvals. Management also acknowledged that B2C remains cyclical and that AI-assisted purchasing is still early, even if growing fast.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 79.6%
- Shares Outstanding
- 34.15M
- Float Shares
- 27.17M
of shares held by institutions
37 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Needham Investment Management LLC | 3.15M | 0 |
| Punch & Associates Investment Management, Inc. | 2.50M | ▼ 52.32K |
| Vanguard Group Inc | 1.26M | ▲ 9.96K |
| Vanguard Capital Management LLC | 1.15M | 0 |
| Luxor Capital Group, LP | 651.96K | 0 |
| Bard Associates Inc | 612.95K | ▲ 3.98K |
| North Star Investment Management Corp. | 410.00K | ▲ 53.00K |
| Perritt Capital Management Inc | 356.82K | 0 |
| Geode Capital Management, LLC | 295.11K | 0 |
| Vanguard Fiduciary Trust Co | 173.88K | 0 |
| Lpl Financial LLC | 146.31K | 0 |
| Navalign, LLC | 146.13K | ▼ 50.00K |
Held by 32 ETFs
Biggest fund positions in RSSS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | MCPEAK MERRILL A | other | 12,500 |
| Nov 16, 26 | Gayron Kenneth L | other | 12,500 |
| Nov 16, 26 | Regazzi John J | other | 15,000 |
| Nov 16, 26 | Murphy Jeremy | other | 12,500 |
| Nov 16, 26 | Cooperman Barbara J. | other | 12,500 |
| Jul 31, 26 | Cohen Sefton | sell | 284,000 |
| Mar 18, 26 | Cohen Sefton | other | 80,000 |
| Dec 10, 25 | Kutil David | other | 30,000 |
| Dec 19, 25 | Kutil David | other | 758 |
| Dec 10, 25 | Kutil David | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RSSS coverage
Recent articles, reports, and earnings notes.
No research on RSSS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RSSS report →Research Solutions, Inc. (RSSS) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 17
What Research Solutions (RSSS) Said on Its Q1 Earnings Call
marketbeat.com · Nov 17
Research Solutions Inc. (RSSS) Q1 Earnings Beat Estimates
zacks.com · Nov 16
Research Solutions Reports First Quarter Fiscal Year 2027 Results
prnewswire.com · Nov 16
Research Solutions Announces Date and Time Change of First Quarter Fiscal Year 2027 Results and Conference Call
prnewswire.com · Nov 11
Research Solutions Announces Agreement With Fortune 500 Biopharma Company Valued at $1 Million
prnewswire.com · Nov 11
Research Solutions (RSSS) Expected to Release Quarterly Earnings on Thursday
defenseworld.net · Nov 11
Research Solutions to Announce First Quarter Fiscal Year 2027 Results on Thursday, November 12, 2026
prnewswire.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.